Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ferric citrate and apo-transferrin enable erythroblast maturation with ℬ-globin from hemogenic endothelium

ABSTRACT: Ferric citrate and apo-transferrin enable erythroblast maturation with ℬ-globin from hemogenic endothelium

PROVIDER: PRJNA947560 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Ferric citrate and apo-transferrin enable erythroblast maturation with β-globin from hemogenic endothelium.

Project description:Red blood cell (RBC) generation from human pluripotent stem cells (PSCs) offers potential for innovative cell therapy in regenerative medicine as well as developmental studies. Ex vivo erythropoiesis from PSCs is currently limited by the low efficiency of functional RBCs with β-globin expression in culture systems. During induction of β-globin expression, the absence of a physiological microenvironment, such as a bone marrow niche, may impair cell maturation and lineage specification. Here, we describe a simple and reproducible culture system that can be used to generate erythroblasts with β-globin expression. We prepared a two-dimensional defined culture with ferric citrate treatment based on definitive hemogenic endothelium (HE). Floating erythroblasts derived from HE cells were primarily CD45+CD71+CD235a+ cells, and their number increased remarkably upon Fe treatment. Upon maturation, the erythroblasts cultured in the presence of ferric citrate showed high transcriptional levels of β-globin and enrichment of genes associated with heme synthesis and cell cycle regulation, indicating functionality. The rapid maturation of these erythroblasts into RBCs was observed when injected in vivo, suggesting the development of RBCs that were ready to grow. Hence, induction of β-globin expression may be explained by the effects of ferric citrate that promote cell maturation by binding with soluble transferrin and entering the cells.Taken together, upon treatment with Fe, erythroblasts showed advanced maturity with a high transcription of β-globin. These findings can help devise a stable protocol for the generation of clinically applicable RBCs.

| S-EPMC10457393 | biostudies-literature

Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

Project description:We aimed to evaluate changes in expression in control and th1/th1 mice treated with PBS and apo-transferrin to understand the effect(s) of exogenous apo-transferrin on normal and ineffective erythropoiesis

2020-10-01 | GSE158839 | GEO

Ferric citrate and apo-transferrin enable erythroblast maturation with ℬ-globin from hemogenic endothelium

Project description:We describe a simple and reproducible culture system that can be used to generate erythroblasts with ℬ-globin expression in culture systems. Upon treatment with Fe, erythroblasts showed advanced maturity with a high transcription of ℬ-globin.

2023-08-31 | GSE227952 | GEO

Ferric Citrate Uptake is a Virulence Factor in Uropathogenic Escherichia coli

Project description:More than half of women will experience a urinary tract infection (UTI) with uropathogenic Escherichia coli (UPEC) causing ~80% of uncomplicated cases. Iron acquisition systems are essential for uropathogenesis, and UPEC encode functionally redundant iron acquisition systems, underlining their importance. However, a recent UPEC clinical isolate, HM7 lacks this functional redundancy and instead encodes a sole siderophore, enterobactin. To determine if E. coli HM7 possesses unidentified iron acquisition systems, we performed RNA-sequencing under iron-limiting conditions and demonstrated the ferric citrate uptake system (fecABCDE and fecIR) was highly upregulated. Importantly, there are high levels of citrate within urine, some of which is bound to iron, and the fec system is highly enriched in UPEC isolates compared to commensal or fecal strains. Therefore, we hypothesized that HM7 and other similar strains use the fec system to acquire iron in the host. Deletion of both enterobactin biosynthesis and ferric citrate uptake (ΔentB/ΔfecA) abrogates use of ferric citrate as an iron source and fecA provides an advantage in pooled human urine in absence of enterobactin. However, in a UTI mouse model, fecA is a fitness factor independent of enterobactin production, likely due to the action of host Lipocalin-2 chelating ferrienterobactin. These findings indicate that ferric citrate uptake is used as an iron source when siderophore efficacy is limited, such as in the host during UTI. Defining these novel compensatory mechanisms and understanding the nutritional hierarchy of preferred iron sources within the urinary tract are important in the search for new approaches to combat UTI.

2021-11-06 | GSE188170 | GEO

Transcription profiling of Neisseria meningitidis strain MC58 grown on RPMI agar containing 10uM Transferrin, 10uM Lactoferrin, 1uM Haemoglobin, or 20uM Ferric chloride

Project description:Transcriptional profiling of Neisseria meningitidis strain MC58 grown on RPMI agar containing 10uM Transferrin, 10uM Lactoferrin, 1uM Haemoglobin, or 20uM Ferric chloride.

2009-02-25 | E-MEXP-1143 | biostudies-arrayexpress

Human holo-transferrin glycation

Project description:Understanding the effect of glycation on the function of transferrin, the systemic iron transporter, is fundamental to fully grasp the mechanisms leading to the loss of iron homeostasis observed in diabetes mellitus (DM). The spontaneous reaction with protein amino groups is one of the main causes of glucose toxicity, but the site specificity of this reaction is still poorly understood. Unbalance of iron metabolism has long been described in DM patients, and one of the main features is the occurrence of non-transferrin-bound iron in the blood serum. The presence of these toxic iron species is observed, despite low transferrin saturation levels. Here in, an in vitro approach was used to study human holo-transferrin glycation in detail. Holo-transferrin was incubated with increasing concentration of glucose (10; 20; 100 and 500 mM) and glycation sites were identified using nano-reverse phase – liquid chromatography coupled to high resolution mass spectrometry (nLC-MS). Overall 21 glycation hotspots were identified with lysine residues 103, 312 and 380 proving to be the most reactive sites. Glycation specificity was found to be remarkably different from that described for apo-transferrin.

2018-05-30 | PXD009345 | Pride

Project description:Micro Ferric Citrate

| PRJNA635162 | ENA

Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

Project description:Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

| PRJNA666678 | ENA

Tindallia californiensis strain:APO

Project description:Tindallia californiensis APO genome sequencing

| PRJNA323219 | ENA

Ferric Citrate Uptake is a Virulence Factor in Uropathogenic Escherichia coli

Project description:Ferric Citrate Uptake is a Virulence Factor in Uropathogenic Escherichia coli

| PRJNA777882 | ENA